Cell Press, Neuron, 3(78), p. 408-410, 2013
DOI: 10.1016/j.neuron.2013.04.030
Full text: Download
In this issue of Neuron, Földy et al. (2013) report that endocannabinoid-mediated signaling at inhibitory synapses is dysregulated in mouse models of autism-associated Neuroligin-3 mutations. These findings carry implications regarding the pathophysiology of autism spectrum disorders and the development of treatment strategies.